Tech Company Financing Transactions
Clock.bio Funding Round
On 8/31/2023, Clock.bio raised $4 million in investment from private investors.
Transaction Overview
Company Name
Announced On
8/31/2023
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company's immediate scientific objective is to decode all rejuvenation programs present in human cells, to build an atlas of disease and rejuvenation targets for clinical translation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
c/o ideaSpace The Clifford Allbutt Building Cambridge Biomed
Cambridge, CB2 0AH
UK
Cambridge, CB2 0AH
UK
Phone
Undisclosed
Website
Email Address
Overview
clock.bio aims to extend and improve quality of life by reversing the harmful effects of time in our cells, harnessing the regenerative capabilities of human pluripotent stem cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Grant Belgard
Co-Founder
Bernhard Klemen
Co-Founder
Mark Kotter
Co-Founder
Florian Schuster
Browse more venture capital transactions:
Prev: 8/31/2023: Alias Technologies venture capital transaction
Next: 8/31/2023: Spencer Health Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs